U.S. Cancer Contrast Media Market Is Expected To Reach $ 1.53 Billion By 2030
San Francisco, 2 April 2024: The Report U.S. Cancer Contrast Media Market Size, Share & Trends Analysis Report By Type (Gadolinium-based Contrast Media, Iodinated Contrast Media), By Modality (Nuclear Imaging, CT scans), By Application (Breast Cancer, Lung Cancer), And Segment Forecasts, 2024 - 2030 The U.S. cancer contrast media market is anticipated to reach USD 1.53 billion by 2030 and is anticipated to expand at a CAGR of 11.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing collaboration and partnerships among key market players, coupled with growing government and private sector R&D investments, alongside the integration of AI in diagnostic imaging enhance the capabilities of contrast media. Thus, these factors collectively propel the growth of U.S. cancer contrast media market. Introducing new products can ignite positive competition among manufacturers, fostering innovation, lowering prices, and ultimately enhancing choices